Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial

Purpose: To develop a novel nomogram for determining radium-223 dichloride (Ra-223) treatment suitability for metastatic castration-resistant prostate cancer (mCRPC) patients. Methods: This Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial was a retrospective multice...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 50; no. 5; pp. 1487 - 1499
Autores principales:	Kitajima, Kazuhiro, Igeta, Masataka, Kuyama, Junpei, Kawahara, Takashi, Suga, Tsuyoshi, Otani, Tomoaki, Sugawara, Shigeyasu, Kono, Yumiko, Tamaki, Yukihisa, Seko-Nitta, Ayumi, Ishiwata, Yoshinobu, Ito, Kimiteru, Toriihara, Akira, Watanabe, Shiro, Hosono, Makoto, Miyake, Hideaki, Yamamoto, Shingo, Narita, Mitsuhiro, Daimon, Takashi, Yamakado, Koichiro
Formato:	Journal Article
Publicado:	Springer Nature Apr2023
Acceso en línea:	Ver este registro en EBSCOhost